Shumpei Asamizu

Dr. Shumpei Asamizu

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2007 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MMMasatomo Makino
Masatomo Makino
HSHiroshi Sugimoto
Hiroshi Sugimoto
YSYoshitsugu Shiro
Yoshitsugu Shiro
SAShumpei Asamizu
Shumpei Asamizu
HOHiroyasu Onaka
Hiroyasu Onaka
SNShingo Nagano
Shingo Nagano
Staurosporine isolated from Streptomyces sp. TP-A0274 is a member of the family of indolocarbazole alkaloids that exhibit strong antitumor activity. A key step in staurosporine biosynthesis is the formation of the indolocarbazole core by intramolecular C–C bond formation and oxidative decarboxylation of chromopyrrolic acid (CPA) catalyzed by cytochrome P450 StaP (StaP, CYP245A1). In this study, we report x-ray crystal structures of CPA-bound and -free forms of StaP. Upon substrate binding, StaP adopts a more ordered conformation, and conformational rearrangements of residues in the active site are also observed. Hydrogen-bonding interactions of two carboxyl groups and T-shaped π–π interactions with indole rings hold the substrate in the substrate-binding cavity with a conformation perpendicular to the heme plane. Based on the crystal structure of StaP–CPA complex, we propose that C–C bond formation occurs through an indole cation radical intermediate that is equivalent to cytochrome c peroxidase compound I [Sivaraja M, Goodin DB, Smith M, Hoffman BM (1989) Science 245:738–740]. The subsequent oxidative decarboxylation reaction is also discussed based on the crystal structure. Our crystallographic study shows the first crystal structures of enzymes involved in formation of the indolocarbazole core and provides valuable insights into the process of staurosporine biosynthesis, combinatorial biosynthesis of indolocarbazoles, and the diversity of cytochrome P450 chemistry.

12 May 2015 in eLife
Verified
Journal Article
Open access
AOAndrew R Osborn
Andrew R Osborn
KAKhaled H Almabruk
Khaled H Almabruk
GHGarrett Holzwarth
Garrett Holzwarth
SAShumpei Asamizu
Shumpei Asamizu
JLJane LaDu
Jane LaDu
TMTaifo Mahmud
Taifo Mahmud
Ultraviolet-protective compounds, such as mycosporine-like amino acids (MAAs) and related gadusols produced by some bacteria, fungi, algae, and marine invertebrates, are critical for the survival of reef-building corals and other marine organisms exposed to high-solar irradiance. These compounds have also been found in marine fish, where their accumulation is thought to be of dietary or symbiont origin. In this study, we report the unexpected discovery that fish can synthesize gadusol de novo and that the analogous pathways are also present in amphibians, reptiles, and birds. Furthermore, we demonstrate that engineered yeast containing the fish genes can produce and secrete gadusol. The discovery of the gadusol pathway in vertebrates provides a platform for understanding its role in these animals, and the possibility of engineering yeast to efficiently produce a natural sunscreen and antioxidant presents an avenue for its large-scale production for possible use in pharmaceuticals and cosmetics.

6 February 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
TOTaro Ozaki
Taro Ozaki
KYKona Yamashita
Kona Yamashita
YGYuki Goto
Yuki Goto
MSMorito Shimomura
Morito Shimomura
SHShohei Hayashi
Shohei Hayashi
HOHiroyasu Onaka
Hiroyasu Onaka
Goadsporin (GS) is a member of ribosomally synthesized and post-translationally modified peptides (RiPPs), containing an N-terminal acetyl moiety, six azoles and two dehydroalanines in the peptidic main chain. Although the enzymes involved in GS biosynthesis have been defined, the principle of how the respective enzymes control the specific modifications remains elusive. Here we report a one-pot synthesis of GS using the enzymes reconstituted in the ‘flexible’ in vitro translation system, referred to as the FIT–GS system. This system allows us to readily prepare not only the precursor peptide from its synthetic DNA template but also 52 mutants, enabling us to dissect the modification determinants of GodA for each enzyme. The in vitro knowledge has also led us to successfully produce designer GS analogues in vivo. The methodology demonstrated in this work is also applicable to other RiPP biosynthesis, allowing us to rapidly investigate the principle of modification events with great ease.

31 March 2015 in Organic Letters
Verified
Journal Article
Closed access
RSRyosuke Sugiyama
Ryosuke Sugiyama
SNShinichi Nishimura
Shinichi Nishimura
TOTaro Ozaki
Taro Ozaki
SAShumpei Asamizu
Shumpei Asamizu
HOHiroyasu Onaka
Hiroyasu Onaka
HKHideaki Kakeya
Hideaki Kakeya

22 April 2009 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YWYong Wang
Yong Wang
HCHui Chen
Hui Chen
MMMasatomo Makino
Masatomo Makino
YSYoshitsugu Shiro
Yoshitsugu Shiro
SNShingo Nagano
Shingo Nagano
SSSason Shaik
Sason Shaik

28 June 2012 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SAShumpei Asamizu
Shumpei Asamizu
PXPengfei Xie
Pengfei Xie
CBCorey J. Brumsted
Corey J. Brumsted
PFPatricia M. Flatt
Patricia M. Flatt
TMTaifo Mahmud
Taifo Mahmud